‘Cancer will be history in 10 years’: Anthropic CEO’s big AI-powered promise

 Anthropic is engaging in partnerships with various biotechnology firms to enhance the pace of drug discovery. These collaborations aim to create solutions for cancer, food allergies, and rare diseases, showcasing notable advancements in T-cell therapies and antibody designs. Furthermore, Anthropic is investigating its own drug innovations targeting muscular dystrophy, though much of the research is still in preclinical phases prior to clinical trials. Anthropic is engaging in partnerships with various biotechnology firms to enhance the pace of drug discovery. These collaborations aim to create solutions for cancer, food allergies, and rare diseases, showcasing notable advancements in T-cell therapies and antibody designs. Furthermore, Anthropic is investigating its own drug innovations targeting muscular dystrophy, though much of the research is still in preclinical phases prior to clinical trials.